Nominating Committee – Undesignated Member

Dr. Pal is co-director of City of Hope's Kidney Cancer Program and is the head of the kidney and bladder cancer disease team at the institution. He is an associate editor for Cancer.Net, previously served as chair of ASCO’s Cancer Communications Committee, and was a 2016-2017 Leadership Development Program participant. He is also a past member of the COVID-19 Response Task Force and Annual Meeting Scientific Program Committee.

Why do you want to serve on the Nominating Committee?

My participation in ASCO has been one of the most rewarding components of my academic career. I have served for 3 years on the Scientific Program Committee and for 6 years on the Cancer Communications Committee (serving as chair in the final portion of that time). Especially in the latter role, I became familiar with the incredible sphere of influence that ASCO has in the oncology clinical, scientific, and patient community. I have been actively involved in several other ASCO efforts such as TAPUR and the Virtual Mentoring Program, giving me unique perspective on the direct role of ASCO in both research and training. Although there are many other ASCO-related efforts I have been involved with, there is no doubt that the most influential has been the ASCO Leadership Development Program. It is through this that I gained insight into the extraordinary tasks set in front of ASCO Executives and Board Members. It is for this reason that I hope to serve on the Nominating Committee – knowing the exceptional character, integrity, and thoughtfulness of existing leadership, I think I am poised to assist in selecting candidates to be amongst the next wave of ASCO leaders.

Vote Now